Analysis
Registration of observational studies: Is it time?
Rebecca J. Williams, Tony Tse, William R. Harlan and Deborah A. Zarin
CMAJ October 19, 2010 182 (15) 1638-1642; DOI: https://doi.org/10.1503/cmaj.092252
Rebecca J. Williams
Tony Tse
William R. Harlan
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Registration of observational studies: Is it time?
Rebecca J. Williams, Tony Tse, William R. Harlan, Deborah A. Zarin
CMAJ Oct 2010, 182 (15) 1638-1642; DOI: 10.1503/cmaj.092252
Jump to section
Related Articles
Cited By...
- Improving the transparency and reliability of observational studies through registration
- Compliance and patient satisfaction with treatment settings recommended by the medical on-call service 116117 in Germany using computer-assisted structured initial assessment: a cross-sectional observational study accompanying the demand intervention
- Transparent reporting of multivariable prediction models developed or validated using clustered data (TRIPOD-Cluster): explanation and elaboration
- Registration of health and medical research
- A priori registration of global health research--necessity or absurdity?
- Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey
- How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider
- Perspective: An Extension of the STROBE Statement for Observational Studies in Nutritional Epidemiology (STROBE-nut): Explanation and Elaboration
- Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013
- Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement
- The Time Has Come to Register Diagnostic and Prognostic Research
- Infrequent and incomplete registration of test accuracy studies: analysis of recent study reports
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
- Strategies for Postmarketing Surveillance of Drugs and Devices in Patients with ESRD Undergoing Dialysis
- Prospective Registration of Marker Evaluation Studies: Time to Act